Journal article
A randomised controlled trial of the effects of albendazole in pregnancy on maternal responses to mycobacterial antigens and infant responses to bacille Calmette-Guérin (BCG) immunisation [ISRCTN32849447]
- Abstract:
-
Background: Maternal schistosomiasis and filariasis have been shown to influence infant responses to neonatal bacille Calmette-Guérin (BCG) immunisation but the effects of maternal hookworm, and of de-worming in pregnancy, are unknown.
Expand abstract
Methods: In Entebbe, Uganda, we conducted a randomised, double-blind, placebo-controlled trial of a single dose of 400 mg of albendazole in the second trimester of pregnancy. Neonates received BCG. Interf...
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 238.4KB, Terms of use)
-
- Publisher copy:
- 10.1186/1471-2334-5-115
Authors
Bibliographic Details
- Publisher:
- BioMed Central
- Journal:
- BMC Infectious Diseases More from this journal
- Volume:
- 5
- Article number:
- 115
- Publication date:
- 2005-12-21
- Acceptance date:
- 2005-12-21
- DOI:
- EISSN:
-
1471-2334
Item Description
- Language:
-
English
- Keywords:
- UUID:
-
uuid:a2eb73ef-aefc-401d-ba63-ed67925c8839
- Local pid:
-
pubs:484108
- Source identifiers:
-
484108
- Deposit date:
-
2014-09-18
Terms of use
- Copyright holder:
- Elliott et al
- Copyright date:
- 2005
- Notes:
- © 2005 Elliott et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record